Second AACR International Conference
Translational Cancer Medicine
Cancer Discoveries for Clinical Application

Held in cooperation with the Latin American Cooperative Oncology Group (LACOG)   

Sept. 27-29, 2018
Grand Hyatt São Paulo
São Paulo, Brazil

Conference Cochairs
Carlos L. Arteaga, UT Southwestern Simmons Cancer Center, Dallas, Texas, USA
Carlos Gil Ferreira, Oncoclinicas Institute, São Paulo, Brazil
Gabriel A. Rabinovich, Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina

  • View Program
  • Watch this message from Conference Cochairs Carlos L. Arteaga and Carlos Gil Ferreira:

Scientific Program Committee
Patricia Ashton-Prolla, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
Carlos H. Barrios, Centro de Pesquisa Clínica Hospital São Lucas, PUCRS, Porto Alegre, Brazil
Roger Chammas, University of São Paulo, São Paulo, Brazil
J. Silvio Gutkind, UCSD Moores Cancer Center, La Jolla, California
Elizabeth M. Jaffee, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, Maryland
Scott Kopetz, The University of Texas MD Anderson Cancer Center, Houston, Texas
Edith Kordon, IFIBYNE, Universidad de Buenos Aires, Buenos Aires, Argentina
Claudia Lanari, Institut de Biología y Medicina Experimental, Buenos Aires, Argentina
Ari M. Melnick, Weill Cornell Medical College, New York, New York
Eduardo Osinaga, Universidad de La República, Montevideo, Uruguay
Kornelia Polyak, Dana-Farber Cancer Institute, Boston, Massachusetts
Rui M. Reis, Barretos Cancer Hospital, Barretos, Brazil
Alice T. Shaw, Massachusetts General Hospital Cancer Center, Boston, Massachusetts
Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, ON, Canada
David B. Solit, Memorial Sloan Kettering Cancer Center, New York, New York
Eduardo Sotomayor, George Washington Cancer Center, Washington, DC
Elba S. Vazquez, Universidad de Buenos Aires, Buenos Aires, Argentina
Luisa L. Villa, Fundação Faculdade de Medicina de São Paulo, São Paulo, Brazil


logo bms-io_v1.jpg

Logo Novartis_novo_png.png

logo Roche.jpg

About the conference
Building on the success of the inaugural Translational Cancer Medicine conference held in 2017 in São Paulo, Brazil, the AACR and LACOG once again partner on a conference that bridges basic and clinical research and will foster translational cancer research in Latin America. This innovative program is designed to appeal to a broad spectrum of cancer researchers—from laboratory scientists to translational cancer researchers to clinical researchers and clinical oncologists in all disciplines of the cancer field—by presenting an overview of state-of-the-art translational cancer research and exploring the latest discoveries in immune checkpoints, precision medicine, epigenetics and metabolism, ex vivo modeling of cancer, virus-induced cancers, the microbiome and cancer, steroid-hormone receptors and cancer, and tumor heterogeneity.


Top of page